HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alice W Racca Selected Research

Hypertrophy

1/2021Loss of crossbridge inhibition drives pathological cardiac hypertrophy in patients harboring the TPM1 E192K mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alice W Racca Research Topics

Disease

2Heart Failure
01/2020 - 02/2015
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2021
1Hypertrophy
01/2021
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2020
1Muscular Dystrophies (Muscular Dystrophy)
01/2020
1Cardiomyopathies (Cardiomyopathy)
01/2020
1Arthrogryposis
06/2015
1Clubfoot (Talipes Equinovarus)
06/2015
1Freeman-Sheldon syndrome
06/2015

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2015
1MYK-461IBA
01/2021
1DystrophinIBA
01/2020
1Myosins (Myosin)IBA
06/2015
1Adenosine Triphosphate (ATP)IBA
02/2015
12'-deoxyadenosine triphosphateIBA
02/2015